Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023

Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others). The report analyses the Antifungal Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India)”, the antifungal drugs market is projected to display a robust growth represented by a CAGR of 3.70% during 2018 – 2023.

Over the recent years, Antifungal Drugs market has been witnessing growth on account of several driving factors including growing prevalence of fungal infections such as candidiasis and aspergillosis, increasing popularity of over-the-counter drugs, and increase in availability of innovative antifungals. Moreover, increasing awareness regarding fatal antifungal diseases, growing medical spending, favorable government initiatives, public private partnership have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in pharmaceuticals research, growing scope in developing countries with large population such as China and India is anticipated to impel the market growth of the antifungal drugs market. However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market performance during forecasted period.

In this research report, the market is segmented on the basis of drug class and therapeutic indications. By drug class, the azoles class antifungals are predicted to hold their dominant position in the market. By therapeutic indications, drugs use in the treatment of candidiasis are anticipated to creates their dominance in global antifungal drugs market. Amongst the regions, North America accounts for the largest regional share in the global antifungal drugs market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and highly advanced medical infrastructure.

The report titled “Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India)”, has covered and analysed the potential of antifungal drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the antifungal drugs. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Antifungal Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Antifungal Drugs Market– Size, Growth, Forecast
  • Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
  • Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Regional Antifungal Drugs Market – North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Antifungal Drugs Market– Size, Growth, Forecast
  • Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
  • Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Country Analysis – U.S., Canada, Germany, U.K, France, China, Japan, India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Antifungal Drugs Market– Size, Growth, Forecast
  • Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
  • Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Other Report Highlights
  • Market Dynamics – Drivers and Restraints.
  • Market Trends.
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis - Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer, Kramer Laboratories, Novartis International AG, Pfizer.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Antifungal Drugs Products Outlook
Table A: Different Types of Common Fungal Diseases
Table B: Different Class of Anti-Fungal Drugs
Table C: Common Invasive Fungal Diseases and Their Treatment Options
Table D: Common Invasive Fungal Diseases and Their Treatment Options
5. Global Antifungal Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
Table 1: Global Antifungal Drugs Market Size, By Value, 2013-2017 (USD Million)
Table E: Burden of Fungal Diseases
Table 2: Number of People Living With HIV, 2013-2017
Table 3: Number of New Cases of Cancer, In 2018, By Type, (% of Total)
Table 4: Estimated TB Incidences, By WHO Regions, 2016
Table 5: Prevalence of Diagnosed Autoimmune Diseases, In 2018, By Selected Countries, (% of Total)
Table 6: Burden of Antifungal Infections, By Type
Table F: Antifungal Compounds in Development Stage – By Phases
Table 7: Generic Market Value Share, In 2006 (Left) &2016 (Right), By Region
Table 8: Global Prescription and OTC Drugs Sales, 2013-2017, (USD Billion)
Table 9: Expected Global Medical Spending in 2020, By Product Type, (% of Total)
Table 10: Expected Global Medical Spending in 2020, By Region, (% of Total)
Table 11: Global Aged Population (Above 65), 2013-2017 (% of total)
Table 12: Global Aged Population(Above 65), By Country, 2017 (% of total)
Table 13: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Table 14: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Table 15: Global Expected Healthcare Industry Outlook
Table 16: Regional Expected Healthcare Industry Growth Rate By Year 2020
5.2 By Value (2018-2023)
Table 17: Global Antifungal Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
6. Global Antifungal Drugs Market: Segmental Analysis
6.1 Global Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
6.1.1 Global Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 18: Global Antifungal Drugs Market Size, By Drug Class, 2017 (%)
6.1.2 Global Antifungal Drugs Market Size, By Drug Class, 2023 (%)
Table 19: Global Antifungal Drugs Market Size, By Drug Class, 2023F (%)
6.2 Global Azole Class Antifungal Drugs Market Size, By Value (2013-2023)
Table 20: Global Azoles Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 21: Global Azoles Antifungal Drugs Market, By Value, 2018-2023(USD Million)
6.3 Global Echinocandins Class Antifungal Drugs Market Size, By Value (2013-2023)
Table 22: Global Echinocandins Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 23: Global Echinocandins Antifungal Drugs Market, 2018-2023(USD Million)
6.4 Global Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
Table 24: Global Polyenes Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 25: Global Polyenes Antifungal Drugs Market, By Value, 2018-2023(USD Million)
6.5 Global Other Antifungal Drugs Market Size, By Value (2013-2023)
Table 24: Global Polyenes Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 25: Global Polyenes Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 28: Market Comparison Chart, By Product Type, 2013-2023 (USD Million)
6.6 Global Antifungal Drugs: Market Attractiveness, By Drug Class
Table 29: Global Market Attractiveness, By Product Type, 2023F
6.7 Global Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
Table 30: Global Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 31: Global Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
6.7.1 Global Aspergillus Antifungal Drugs Market Size, By Value (2013-2023)
6.7.2 Global Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
6.7.3 Global Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
6.6.2 Global Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
7. Global Antifungal Drugs Market: Regional Analysis
7.1 Global Antifungal Drugs Market Size, By Region : Breakdown (%)
7.1.1 Global Antifungal Drugs Market Size, By Region, 2017 (%)
Table 34: Global Antifungal Drugs Market Size, By Region, 2017 (%)
7.1.2 Global Antifungal Drugs Market Size, By Region, 2023 (%)
Table 35: Global Antifungal Drugs Market Size, By Region, 2023F (%)
8. North America Antifungal Drugs Market: An Analysis
8.1 North America Antifungal Drugs Market: Segment Analysis
Table 36: North America Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 37: United States Spending on Medicines, 2013-2017 (In USD Billion)
Table 38: Patented and Non-Patented Drugs Sales in Canada, 2013-2016 (USD Billion)
Table 39: North America Diseases Outlook
Table 40: United States health care expenditure per capita,2013-2016(USD)
Table 41: Canada health care expenditure per capita,2013-2016(USD)
Table 42: North America population aged 65 and above, 2013-2017 (% of total)
Table 43: North America Healthcare Cost Per Capita, 2017 (USD)
Table 44: North America GDP per Capita, 2013-2017 (USD)
Table 45: North America Antifungal Drugs Market, By Value, 2018-2023 (USD Million)
8.2 North America Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
8.2.1 North America Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 46: North America Antifungal Drugs Market Size, By Drug Class, 2017 (%)
8.2.2 North America Antifungal Drugs Market Size, By Drug Class, 2023 (%)
Table 47: North America Antifungal Drugs Market Size, By Drug Class, 2023F (%)
8.3 North America Azoles Antifungal Drugs Market Size, By Value (2013-2023)
Table 48: North America Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
8.4 North America Echinocandins Antifungal Drugs Market Size, By Value (2013-2023)
8.5 North America Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
8.6 North America Others Antifungal Drugs Market Size, By Value (2013-2023)
8.7 North America Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
Table 49: North America Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 50: North America Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 51: North America Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 52: North America Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 53: North America Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 54: North America Antifungal Drugs Market Size, By Countries, 2023F (%)
8.7.1 North America Aspergillus Antifungal Drugs Size, By Value (2013-2023)
8.7.2 North America Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
8.7.3 North America Candidiasis Antifungal Drugs Size, By Value (2013-2023)
8.7.4 North America Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
8.8 North America Antifungal Drugs Market: Country Analysis (U.S and Canada)
8.8.1 U.S Antifungal Drugs Market, By Value (2013-2023)
Table 55: USA Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 56: USA Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 57: United States Fungal Infection Facts & Tables
Table 58: New Patients Diagnosed with HIV in 2017, By Age Group
Table 59: United States Per Capita Spending on Medicines, 2013-2017 (In USD)
Table 60: Pharmacy & Drug Store Sales in United States, 2013-2016 (In USD Billion)
Table 61: Medical and Healthcare Research & Development Spending, 2013-2016 (In USD Million)
Table 62: U.S., Population ages 65 and above, 2013-2017 (% of total)
Table 63: U.S., Population ages 65 and above, Forecast (In Millions)
Table 64: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Table 65: U.S., GDP (Current USD), 2013-2017 (In USD Trillion)
Table 66: USA Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 67: USA Antifungal Drugs Market Size, By Drug Class, 2023F (%)
8.8.2 U.S Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 68: USA Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
8.8.3 U.S Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 69: USA Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 70: USA Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 71: USA Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 72: USA Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 73: Leading Antifungal Drugs Companies In The United States of America
8.8.4 Canada Antifungal Drugs Market, By Value (2013-2023)
Table 74: Canada Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 75: Canada Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 76: Estimated Number of Serious Fungal Infections Cases in Canada, 2014
Table 77: Estimated Number of Mucosal Candidiasis in Canada, 2014
Table 78: Estimated Number of Opportunistic Invasive Fungal Infections Cases in Canada, 2014
Table 79: Estimated Number of Endemic Mycoses Cases in Canada, 2014
Table 80: Estimated Number of Non-Invasive Pulmonary Aspergillosis Cases in Canada, 2014
Table 81: Number of Retail Pharmacies in Canada, 2013-2017
Table 82: Number of Hospitals Establishments in Canada, By Province, 2015
Table 83: Number HIV Cases in Canada, 2013-2016
Table 84: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Table 85: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Table 86: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
8.8.5 Canada Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 87: Canada Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 88: Canada Antifungal Drugs Market Size, By Drug Class, 2023F (%)
Table 89: Canada Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
8.8.6 Canada Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 90: Canada Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 91: Canada Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 92: Canada Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 93: Canada Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 94: Leading Antifungal Drugs Companies In Canada
9. Europe Antifungal Drugs Market: An Analysis
9.1 Europe Antifungal Drugs Market: Segmental Analysis
Table 95: Europe Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 96: Europe Health Expenditure, By Select Country, 2016 (% of GDP)
Table G: EU-5 Socio-Economical Statistics, 2017
Table 97: Europe Population ages 65 years and above (% of total population), 2013-17
Table 98: Europe, Fungal Infections Burden, (Per 100000 population), By Selected Countries
Table 99: Europe Antifungal Drugs Market, By Value, 2018-2023 (USD Million)
9.2 Europe Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
9.1.2 Europe Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 100: Europe Antifungal Drugs Market Size, By Drug Class, 2017 (%)
9.1.3 Europe Antifungal Drugs Market Size, By Drug Class, 2023 (%)
Table 101: Europe Antifungal Drugs Market Size, By Drug Class, 2023F (%)
9.3 Europe Azoles Antifungal Drugs Market Size, By Value (2013-2023)
Table 102: Europe Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
9.4 Europe Echinocandins Drugs Market Size, By Value (2013-2023)
9.5 Europe Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
9.6 Europe Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
Table 103: Europe Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 104: Europe Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
9.6.1 Europe Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023)
Table 105: Europe Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
9.6.2 Europe Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
Table 106: Europe Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
9.6.3 Europe Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
9.6.4 Europe Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
Table 107: Europe Antifungal Drugs Market Size, By Countries, 2017 (%)
Table 108: Europe Antifungal Drugs Market Size, By Countries, 2023F (%)
9.7 Europe Antifungal Drugs Market: Country Analysis (Germany, France, Italy, U.K)
9.7.1 Germany Antifungal Drugs Market, By Value (2013-2023)
Table 109: Germany Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 110: Germany Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 111: Germany, Healthcare Related Statistics, 2017
Table H: Germany, Fungal Infection Burden
Table 112: Germany, Leukemia Incidences, 2014 & 2018E
Table 113: Germany, Population ages 65 and above, 2012-2017 (% total)
Table 114: Germany, Cause of Deaths, Percentage Change ,2007-2017
Table 115: Germany, Cause of Deaths, Percentage Change ,2007-2017
Table 116: Germany, HIV Prevalence, 2013-2017
Table 117: Germany, Prevalence of Cancer, 2018 (% of total)
9.7.2 Germany Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 118: Germany Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 119: Germany Antifungal Drugs Market Size, By Drug Class, 2023F (%)
Table 120: Germany Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
9.7.3 Germany Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 121: Germany Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 122: Germany Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 123: Germany Antifungal Drugs Market, By herapeutic Indications , By Value, 2013-2017 (USD Million)
Table 124: Germany Antifungal Drugs Market, By herapeutic Indications , By Value, 2013-2017 (USD Million)
Table 125: Leading Antifungal Drugs Companies In Germany
9.7.4 France Antifungal Drugs Market, By Value (2013-2023)
Table 126: France Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 127: France Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 128: France, Healthcare Infrastructure Related Statistics
Table 129: France, Health Expenditure, (% of GDP), 2012-2015 (USD)
Table 130: France, Population Ages 65 and Above (% of total), 2012-2017
Table 131: France, Prevalence of Cancer, 2018, (% of total)
Table 132: France, Spending on Healthcare, 2015 & 2040$, (USD Per Person)
9.7.5 France Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 133: France Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 134: France Antifungal Drugs Market Size, By Drug Class, 2023F (%)
Table 135: France Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
9.7.6 France Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 136: France Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 137: France Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 138: France Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 139: France Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 140: Leading Antifungal Drugs Companies In France
9.7.7 UK Antifungal Drugs Market, By Value (2013-2023)
Table 141: U.K Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 142: U.K Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 143: U.K, Health Expenditure, (% of GDP), 2013-2017 (USD)
Table 144: U.K, Population Ages 65 and Above (% of total), 2012-2017
Table 145: UK, Prevalence of Cancer, 2018, (% of Total)
Table 146: U.K, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Table 147: UK, Healthcare Infrastructure Related Statistics
Table 148: Candidaemia per 100,000 population by region (England, Wales and Northern Ireland), 2013-2017
9.7.8 UK Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 149: U.K Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 150: U.K Antifungal Drugs Market Size, By Drug Class, 2023F (%)
Table 151: U.K Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
9.7.9 UK Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 152: U.K Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 153: U.K Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 154: U.K Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 155: U.K Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 156: Leading Antifungal Drugs Companies In U.K
10. APAC Antifungal Drugs Market: An Analysis
10.1 APAC Antifungal Drugs Market: Segmental Analysis
Table 157: APAC Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 158: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Table 159: Population ages 65 and above, By Select Country, 2017 (% of total)
Table 160: Cancer Incidences in Asia, (% of Total), 2018
Table 161: China, Pharmaceuticals Industry Revenue (USD Billion)
Table 162: Japan, Total Drugs Market, 2013-2017, USD Billion
Table 163: India Pharma Market, 2015-2017, (USD Billion)
Table 164: APAC Antifungal Drugs Market, By Value, 2018-2023 (USD Million)
10.2 APAC Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
10.2.1 APAC Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 165: APAC Antifungal Drugs Market Size, By Drug Class, 2017 (%)
10.2.2 APAC Antifungal Drugs Market Size, By Drug Class, 2023 (%)
Table 166: APAC Antifungal Drugs Market Size, By Drug Class, 2023F (%)
10.3 APAC Azole Antifungal Drugs Market Size, By Value (2013-2023)
10.4 APAC Echinocandins Antifungal Drugs Market Size, By Value (2013-2023)
10.5 APAC Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
10.6 APAC Other Antifungal Drugs Market Size, By Value (2013-2023)
Table 167: APAC Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
10.7 APAC Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
Table 168: APAC Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 169: APAC Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
10.7.1 APAC Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023)
10.7.2 APAC Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
10.7.3 APAC Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
10.7.4 APAC Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
Table 170: APAC Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 171: APAC Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 172: APAC Antifungal Drugs Market Size, By Countries, 2017 (%)
Table 173: APAC Antifungal Drugs Market Size, By Countries, 2023F (%)
10.8 APAC Antifungal Drugs Market: Country Analysis (China, Japan, and India)
10.8.1 China Antifungal Drugs Market, By Value (2013-2023)
Table 174: China Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 175: China Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 176: China, Fungal Infections Facts & Tables
Table 177: China, Number of HIV Patients
Table 178: China, Cancer Incidences ( in Million)
Table 179: China, GDP Growth Per Year, 2015-2019 (In %)
Table 180: China, Share of Urban Population, 2012-2017 (In %)
Table 181: China, Total Population, 2013-2021F (In Billion)
10.8.2 China Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 182: China Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 183: China Antifungal Drugs Market Size, By Drug Class, 2023F (%)
Table 184: China Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
10.8.3 China Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 185: China Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 186: China Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 187: China Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 188: China Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 189: Leading Antifungal Drugs Companies In China
10.8.4 Japan Antifungal Drugs Market, By Value (2013-2023)
Table 190: Japan Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 191: Japan Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 192: Japan, Population ages 65 and above, 2012-2017 (% of total)
Table 193: Japan, HIV Prevalence, 2017
Table 194: Japan, Medical Facilities Outlook
Table 195: Japan Healthcare Expenditure Outlook (%)
Table 196: Japan, GDP Growth Per Year, 2015-2019F (In %)
Table 197: Japan, Population ages 65 and above, 2012-2016 (% of total)
10.8.5 Japan Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 198: Japan Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 199: Japan Antifungal Drugs Market Size, By Drug Class, 2023F (%)
Table 200: Japan Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
10.8.6 Japan Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 201: Japan Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 202: Japan Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 203: Japan Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 204: Japan Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023 (USD Million)
Table 205: Leading Antifungal Drugs Companies In Japan
10.8.7 India Antifungal Drugs Market, By Value (2013-2023)
Table 206: India Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 207: India Antifungal Drugs Market, By Value, 2018-2023(USD Million)
Table 208: India, Fungal Infection Facts & Tables
Table 209: India, Diseases & Medical Industry Outlook
Table 210: India, Population ages 65 and above, 2013-2017
Table 211: India, Total Population, 2013-2023F (In Billion)
Table 212: Pharma Export From India Market, 2013-2017, (USD Billion)
10.8.8 India Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
Table 213: India Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 214: India Antifungal Drugs Market Size, By Drug Class, 2023F (%)
Table 215: India Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
10.8.9 India Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)
Table 216: India Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 217: India Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
Table 218: India Antifungal Drugs Market, By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 219: India Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 220: Leading Antifungal Drugs Companies In India
11. ROW Antifungal Drugs Market: Growth and Forecast
11.1 ROW Antifungal Drugs Market: Segmental Analysis
Table 221: ROW Antifungal Drugs Market, By Value, 2013-2017 (USD Million)
Table 222: Fungal Infection Burden in Latin America & Egypt, By Selected Countries
Table 223: HIV Prevalence in LA&C and MENA (% of total), 2018
Table 224: Cancer Prevalence in MENA (% of total), 2018
Table 225: Cancer Prevalence in Latin America & Caribbean , (% of total), 2018
Table 226: GDP Per Capita in ROW, By Select Country, 2013 (In USD)
Table 227: GDP Per Capita in ROW, By Select Country, 2017 (In USD)
Table 228: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total)
Table 229: Middle East and North Africa, Population ages 65 and above (% of total)
Table 230: ROW Antifungal Drugs Market, By Value, 2018-2023 (USD Million)
11.2 ROW Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
11.1.1 ROW Antifungal Drugs Market Size, By Drug Class, 2017 (%)
Table 231: ROW Antifungal Drugs Market Size, By Drug Class, 2017 (%)
11.1.2 ROW Antifungal Drugs Market Size, By Drug Class, 2023 (%)
Table 232: ROW Antifungal Drugs Market Size, By Drug Class, 2023F (%)
11.3 ROW Azole Antifungal Drugs Market Size, By Value (2013-2023)
11.4 ROW Echinocandins Antifungal Drugs Market Size, By Value (2013-2023)
11.5 ROW Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
11.6 ROW Other Antifungal Drugs Market Size, By Value (2013-2023)
Table 233: ROW Antifungal Drugs Market, By Drug Class, By Value, 2013-2017 (USD Million)
11.7 ROW Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
Table 234: ROW Antifungal Drugs Market Size, By Therapeutic Indications , 2017 (%)
Table 235: ROW Antifungal Drugs Market Size, By Therapeutic Indications , 2023F (%)
11.7.1 ROW Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023)
11.7.2 ROW Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
11.7.3 ROW Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
11.7.4 ROW Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
Table 236: ROW Antifungal Drugs Market,By Therapeutic Indications , By Value, 2013-2017 (USD Million)
Table 237: ROW Antifungal Drugs Market, By Therapeutic Indications , By Value, 2018-2023(USD Million)
Table 238: Branded Antifungal Drugs Sales, 2017, (USD Million)
12. Global Antifungal Drugs Market: Market Dynamics
12.1 Global Antifungal Drugs Market Drivers
12.2 Global Antifungal Drugs Market Restrains
12.3 Global Antifungal Drugs Market Trends
13. Porter Five Force Analysis
14. SWOT Analysis
15. Antifungal Drugs Market – Competitive Landscape
16. Company Profiles
16.1 Merck & Co.
Table 239: Merck & Co., Revenues 2013-2017(USD Million)
Table 240: Merck & Co., Revenues, By Region, 2017(% of Total)
Table 241: Merck & Co., Revenues, By Region, 2017(% of Total)
16.2 Pfizer
Table 242: Pfizer, Net Sales, 2013-2017 (USD Million)
Table 243: Pfizer, Revenue, By Segments, 2017 (%)
Table 244: Pfend, Net Sales, 2015-2017 (USD Million)
16.3 GSK
Table 245: GSK, Revenues, 2013-2017 (USD Million)
Table 246: GSK, Revenue, By Region, 2017 (USD Million)
Table 247: GSK, Revenue, By Segments, 2017(%)
Table 248: GSK, Revenue, By Pharmaceuticals Segment, 2017 (USD Million)
16.4 Novartis
Table 249: Novartis, Net Sales, 2013-2017 (USD Million)
Table 250: Novartis, Revenue, By Segment, 2017(%)
Table 251: Novartis, Revenue, By Region, 2017(%)
16.5 Abbott Laboratories
Table 252: Abbott Laboratories, Net Sales, 2013-2017 (USD Million)
Table 253: Abbott Laboratories, Revenue, By Segments, 2017(%)
Table 254: Abbott Laboratories, Revenue, By Regions, 2017(%)
16.6 Astellas Pharma
Table 255: Astellas, Net Sales, 2013-2017 (USD Million)
Table 256: Astellas, Revenue, By Regions, 2017(%)
Table 257: Astellas, Revenue, By Segments, 2017(%)
16.7 Bayer
Table 258: Bayer, Net Sales, 2013-2017 (USD Million)
Table 259: Bayer, Net Sales, 2013-2017 (USD Million)
Table 260: Bayer, Revenue, By Segments, 2017(%)
16.8 Sanofi
Table 261: Sanofi, Net Sales, 2013-2017 (USD Million)
Table 262: Bio-Rad Revenue, By Region, 2017(%)
16.9 Kramer Laboratories

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook